 WOODSTOCK, Ga.--BUSINESS WIRE--Sonoma Pharmaceuticals, Inc. Nasdaq: SNOA, a global healthcare leader developing and producing stabilized hypochlorous acid HOCl products for a wide range of applications, including wound care, eye, oral and nasal care and dermatological conditions today announced financial results for fiscal year 2021 and the fourth quarter ended March 31, 2021. For the past 18 months we have been restructuring the Company to cut losses while positioning it for growth, sa 